The purpose of this research study is to see if using a combination of medications will work better than placebo to treat methamphetamine use disorder. The two medications to be tested are bupropion (also called Wellbutrin) and naltrexone (also called Vivitrol).
The purpose of this study is to see if a combined treatment of injectable extended-release naltrexone (XR-NTX; Vivitrol®) and injectable extended-release Buprenorphine (XR-BUP; Sublocade®) are safe and effective for helping people cut down or stop using cocaine.
A Phase 2, Open-Label, Multicenter, Randomized Study to Evaluate the Pharmacokinetics and Safety of Twice Yearly Long-Acting Subcutaneous Lenacapavir for Pre-Exposure Prophylaxis in People Who Inject Drugs.
Tailoring mobile health tools for HIV PrEP support among Young Latino/e/x Cisgender Men and Gender Nonbinary Persons Assigned Male at Birth who have Sex with Men in the Americas: a sub-study to HPTN 113